Impact of Sars-CoV-2 Prophylaxis With Tixagevimab-Cilgavimab in High-Risk Patients With B-Cell Malignancies: A Single-Center Retrospective Study. Mediterr J Hematol Infect Dis 2023, 15 (1), e2023061. https://doi.org/10.4084/MJHID.2023.061.